TFF1 mRNA abundance in GAS-KO mice was reduced to 63.0 ± 7.0 % of that in WT controls (mean ± S.E.M., P < 0.05, Student’s unpaired t test, n = 5) and increased in a hypergastrinaemic transgenic strain (INS-GAS) to 142.0 ± 10.0 % that of WT controls (P < 0.05). TFF1 mRNA abundance was acutely regulated by gastrin (10-8 M) in AGS-GR cells, increasing to 14.3 ± 3.6-fold above vehicle treated controls (P < 0.02, n = 3) after 3 h and 30.1 ± 6.3-fold after 15 h. A fragment of approximately 1.4 kilobases of the human TFF1 promoter was cloned into the luciferase reporter vector pXP2. Luciferase expression in AGS-GR cells was dose-dependently increased by gastrin (779 ± 137 % of that of vehicle control, P < 0.001, n = 9, with 10-9 M gastrin). TFF1-luciferase expression was induced both directly, and by transactivation through neighbouring cells. The response to gastrin mapped to a 16 bp GC-rich region incorporating overlapping consensus binding sites for the transcription factors SP1 and MAZ. Mutation through this region reduced gastrin-stimulated luciferase expression to between 15 and 36 % of that seen with WT constructs (P < 0.05, n = 3, ANOVA). In EMSAs a radiolabelled probe corresponding to this 16bp region of the TFF1 promoter bound to nuclear extracts from gastrin-stimulated but not unstimulated AGS-GR cells. Binding was dependent upon intact SP1 and MAZ consensus sites, and was disrupted by incubation with antibodies to MAZ or SP3.
We conclude that gastrin exerts tonic control of TFF1 expression, but also has the potential for rapid up-regulation of this trefoil factor. TFF1 is a potential candidate to counter the proliferative effects of gastrin that may occur in response to mucosal injury.
This work is supported by the Wellcome Trust and MRC.